mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-07 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |